Axena Health, which makes a digital therapeutic for women's pelvic health, has partnered with the direct-to-consumer telehealth company UpScriptHealth to offer consultation and treatment to women suffering from urinary incontinence symptoms.
Axena's Leva Pelvic Health System aids in pelvic floor muscle training (PFMT), which is a first-line treatment that can be completed at home.
The system is...
Axena Health, which makes a women's pelvic health digital therapeutic, announced it had raised a $25 million Series A investment from XA IM Alts.
WHAT THEY DO
Axena offers the Leva Pelvic Health System, a prescription digital therapeutic aimed at treating urinary incontinence and chronic fecal incontinence in women. The system, which has received FDA 510(k) clearance, includes a vaginal motion...
Digital musculoskeletal care company Hinge Health launched a women's pelvic health program, nearly two months after competitor SWORD Health revealed a similar offering.
Hinge's program, available within the same platform as the rest of its MSK tools, offers educational content and access to a care team made up of physical therapists, women's health coaches and urogynecologists. The offering can...
Digital musculoskeletal care company SWORD Health has launched its own women's physical therapy product focused on pelvic health and pain.
Bloom includes a sensor that measures pressure and stamina of the pelvic floor and connects an app so users can receive feedback on their exercises. Members are also paired with a pelvic health specialist who can guide them through exercises and make changes...
Renovia, a digital therapeutics maker for female pelvic floor disorders, today shared the closing of its Series C-1 financing round worth $17 million.
The round included previous backers including Perceptive Life Sciences, Longwood Fund, Ascension Ventures and OSF Ventures, in addition to new investor Parian Global Management.
WHAT THEY DO
Renovia's flagship product, leva, is an FDA-cleared...
Last week Renovia, maker of an FDA-cleared, app-based system for pelvic floor disorder management and therapy, announced the closure of a $32.3 million Series B equity round and an additional $10 million of debt financing. The round was led by Perceptive Advisors and Ascension Ventures, with additional participation from Longwood Fund, Inova Strategic Investments, Cormorant Asset Management, OSF...
